Sangamo BioSciences



Ebitda تغيير تاريخ
Alaunos Therapeutics USD 16.01M 17.16M 2024-10
Alnylam Pharmaceuticals USD 32.48M 123.47M 2025-03
Amgen USD 3.75B 42M 2025-03
Bayer EUR 3.59B 1.92B 2025-03
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 245.96M 51.11M 2025-03
Cipla INR 15.38B 4.51B 2025-03
Clal Biotechnology ILS -5295000 2.09M 2022-12
Compugen -7483000 4.07M 2024-12
CSL USD 3.23B 1.52B 2024-12
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
Grifols EUR 536.1M 71.58M 2024-12
Ionis Pharmaceuticals USD -141463000 35.91M 2025-03
J&J USD 7.88B 1.76B 2025-03
Merck USD 7.74B 625M 2025-03
Novartis USD 5.19B 319M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 2.86B 2.3B 2025-03
Sarepta Therapeutics USD -290408000 472.62M 2025-03
Tectonic Therapeutic USD -13483000 5.73M 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Sangamo BioSciences - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.